COMP <GO>
ZTS vs UNH // FORWARD P/E MULTIPLE
Zoetis Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: ZTS 9
— UNH 4
▲ FORWARD P/E MULTIPLE LEADER: ZTS
LAST: $83.18 (+4.34%) • MKT CAP: $32.94B
forward-pe
11.3x
LAST: $400.44 (-1.60%) • MKT CAP: $365.29B
forward-pe
17.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZTS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZTS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 71.80% | 88.57% | -16.77 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 25.70% | 11.47% | +14.23 | ZTS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.3x | 16.5x | -6.18 | ZTS | /valuation <GO> |
| Free Cash Flow Yield | 7.01% | 6.47% | +0.54 | ZTS | /fcf-yield <GO> |
| Operating Margin | 34.40% | 4.82% | +29.58 | ZTS | /operating-margins <GO> |
| Net Profit Margin | 28.20% | 3.14% | +25.06 | ZTS | /net-margins <GO> |
| Revenue Growth (YoY) | 2.30% | 6.46% | -4.16 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.32% | -2.32 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.53 | 3.12 | +1.41 | ZTS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.11% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.6 | 57.4 | +2.20 | ZTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.99 | 0.33 | +0.66 | ZTS | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 11.3x | 17.7x | -6.44 | ZTS | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $32.94B | $365.29B | -$332.35B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZTS REV | UNH REV | ZTS GROSS % | UNH GROSS % | ZTS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.47B | $447.57B | 71.8% | 88.7% | $2.28B | $16.07B |
| FY 2024 | $9.26B | $400.28B | 70.6% | 88.3% | $2.30B | $20.70B |
| FY 2023 | $8.54B | $371.62B | — | 89.6% | $1.97B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZTS // BETA 0.99
UNH // BETA 0.33